Brief: Evotec 2026 Guidance Confirmed
06/05/2026 06:33
May 6 (Reuters) - EVOTEC SE EVTG.DE: 2026 GUIDANCE CONFIRMED Q1 CONSOLIDATED REVENUE OF €156.6 MILLION Q1 ADJUSTED GROUP EBITDA OF €-21.9 MILLION Further company coverage: EVTG.DE (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Evotec SE
See all newsEvotec up 7% in early trade after 9-month revenue, earnings beat
Brief: Evotec Says Preliminary Nine-Month 2026 Results Above Market Expectations
Brief: Evotec Initiates Phase 1 Trial For Jst-018 Antibodies Targeting Orthopoxviruses
Brief: EVOTEC Q2 Group Revenues €143.50 Mln
Brief: Evotec And Odyssey Therapeutics Enter AI-Enabled R&D Collaboration In Autoimmune And Inflammatory Diseases